3.23.2 html 159 279 1 true 54 0 false 6 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.harvardbioscience.com/20230630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://www.harvardbioscience.com/20230630/role/statement-consolidated-balance-sheets-unaudited Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://www.harvardbioscience.com/20230630/role/statement-consolidated-balance-sheets-unaudited-parentheticals Consolidated Balance Sheets (Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://www.harvardbioscience.com/20230630/role/statement-consolidated-statements-of-operations-unaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://www.harvardbioscience.com/20230630/role/statement-consolidated-statements-of-comprehensive-loss-unaudited Consolidated Statements of Comprehensive Loss (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.harvardbioscience.com/20230630/role/statement-consolidated-statements-of-stockholders-equity-unaudited Consolidated Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.harvardbioscience.com/20230630/role/statement-consolidated-statements-of-cash-flows-unaudited Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - Note 1 - Basis of Presentation and Summary of Significant Accounting Policies, and Risks and Uncertainties Sheet http://www.harvardbioscience.com/20230630/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies-and-risks-and-uncertainties Note 1 - Basis of Presentation and Summary of Significant Accounting Policies, and Risks and Uncertainties Notes 8 false false R9.htm 008 - Disclosure - Note 2 - Recently Issued Accounting Pronouncements Sheet http://www.harvardbioscience.com/20230630/role/statement-note-2-recently-issued-accounting-pronouncements Note 2 - Recently Issued Accounting Pronouncements Notes 9 false false R10.htm 009 - Disclosure - Note 3 - Goodwill and Intangible Assets Sheet http://www.harvardbioscience.com/20230630/role/statement-note-3-goodwill-and-intangible-assets Note 3 - Goodwill and Intangible Assets Notes 10 false false R11.htm 010 - Disclosure - Note 4 - Balance Sheet Information Sheet http://www.harvardbioscience.com/20230630/role/statement-note-4-balance-sheet-information Note 4 - Balance Sheet Information Notes 11 false false R12.htm 011 - Disclosure - Note 5 - Leases Sheet http://www.harvardbioscience.com/20230630/role/statement-note-5-leases Note 5 - Leases Notes 12 false false R13.htm 012 - Disclosure - Note 6 - Long-term Debt Sheet http://www.harvardbioscience.com/20230630/role/statement-note-6-longterm-debt Note 6 - Long-term Debt Notes 13 false false R14.htm 013 - Disclosure - Note 7 - Derivatives Sheet http://www.harvardbioscience.com/20230630/role/statement-note-7-derivatives Note 7 - Derivatives Notes 14 false false R15.htm 014 - Disclosure - Note 8 - Fair Value Measurements Sheet http://www.harvardbioscience.com/20230630/role/statement-note-8-fair-value-measurements Note 8 - Fair Value Measurements Notes 15 false false R16.htm 015 - Disclosure - Note 9 - Capital Stock and Stock-based Compensation Sheet http://www.harvardbioscience.com/20230630/role/statement-note-9-capital-stock-and-stockbased-compensation Note 9 - Capital Stock and Stock-based Compensation Notes 16 false false R17.htm 016 - Disclosure - Note 10 - Revenues Sheet http://www.harvardbioscience.com/20230630/role/statement-note-10-revenues Note 10 - Revenues Notes 17 false false R18.htm 017 - Disclosure - Note 11 - Income Tax Sheet http://www.harvardbioscience.com/20230630/role/statement-note-11-income-tax- Note 11 - Income Tax Notes 18 false false R19.htm 018 - Disclosure - Note 12 - Commitments and Contingent Liabilities Sheet http://www.harvardbioscience.com/20230630/role/statement-note-12-commitments-and-contingent-liabilities Note 12 - Commitments and Contingent Liabilities Notes 19 false false R20.htm 019 - Disclosure - Note 13 - Litigation Settlement Sheet http://www.harvardbioscience.com/20230630/role/statement-note-13-litigation-settlement Note 13 - Litigation Settlement Notes 20 false false R21.htm 020 - Disclosure - Note 14 - Product Line Disposition Sheet http://www.harvardbioscience.com/20230630/role/statement-note-14-product-line-disposition Note 14 - Product Line Disposition Notes 21 false false R22.htm 021 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.harvardbioscience.com/20230630/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.harvardbioscience.com/20230630/role/statement-note-1-basis-of-presentation-and-summary-of-significant-accounting-policies-and-risks-and-uncertainties 22 false false R23.htm 022 - Disclosure - Note 3 - Goodwill and Intangible Assets (Tables) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-3-goodwill-and-intangible-assets-tables Note 3 - Goodwill and Intangible Assets (Tables) Tables http://www.harvardbioscience.com/20230630/role/statement-note-3-goodwill-and-intangible-assets 23 false false R24.htm 023 - Disclosure - Note 4 - Balance Sheet Information (Tables) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-4-balance-sheet-information-tables Note 4 - Balance Sheet Information (Tables) Tables http://www.harvardbioscience.com/20230630/role/statement-note-4-balance-sheet-information 24 false false R25.htm 024 - Disclosure - Note 5 - Leases (Tables) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-5-leases-tables Note 5 - Leases (Tables) Tables http://www.harvardbioscience.com/20230630/role/statement-note-5-leases 25 false false R26.htm 025 - Disclosure - Note 6 - Long-term Debt (Tables) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-6-longterm-debt-tables Note 6 - Long-term Debt (Tables) Tables http://www.harvardbioscience.com/20230630/role/statement-note-6-longterm-debt 26 false false R27.htm 026 - Disclosure - Note 7 - Derivatives (Tables) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-7-derivatives-tables Note 7 - Derivatives (Tables) Tables http://www.harvardbioscience.com/20230630/role/statement-note-7-derivatives 27 false false R28.htm 027 - Disclosure - Note 8 - Fair Value Measurements (Tables) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-8-fair-value-measurements-tables Note 8 - Fair Value Measurements (Tables) Tables http://www.harvardbioscience.com/20230630/role/statement-note-8-fair-value-measurements 28 false false R29.htm 028 - Disclosure - Note 9 - Capital Stock and Stock-based Compensation (Tables) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-9-capital-stock-and-stockbased-compensation-tables Note 9 - Capital Stock and Stock-based Compensation (Tables) Tables http://www.harvardbioscience.com/20230630/role/statement-note-9-capital-stock-and-stockbased-compensation 29 false false R30.htm 029 - Disclosure - Note 10 - Revenues (Tables) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-10-revenues-tables Note 10 - Revenues (Tables) Tables http://www.harvardbioscience.com/20230630/role/statement-note-10-revenues 30 false false R31.htm 030 - Disclosure - Note 3 - Goodwill and Intangible Assets (Details Textual) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-3-goodwill-and-intangible-assets-details-textual Note 3 - Goodwill and Intangible Assets (Details Textual) Details http://www.harvardbioscience.com/20230630/role/statement-note-3-goodwill-and-intangible-assets-tables 31 false false R32.htm 031 - Disclosure - Note 3 - Goodwill and Intangible Assets - Change in Carrying Amount of Goodwill (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-3-goodwill-and-intangible-assets-change-in-carrying-amount-of-goodwill-details Note 3 - Goodwill and Intangible Assets - Change in Carrying Amount of Goodwill (Details) Details 32 false false R33.htm 032 - Disclosure - Note 3 - Goodwill and Intangible Assets - Intangible Assets (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-3-goodwill-and-intangible-assets-intangible-assets-details Note 3 - Goodwill and Intangible Assets - Intangible Assets (Details) Details 33 false false R34.htm 033 - Disclosure - Note 3 - Goodwill and Intangible Assets - Future Amortization Expense of Intangible Assets (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-3-goodwill-and-intangible-assets-future-amortization-expense-of-intangible-assets-details Note 3 - Goodwill and Intangible Assets - Future Amortization Expense of Intangible Assets (Details) Details 34 false false R35.htm 034 - Disclosure - Note 4 - Balance Sheet Information - Inventories (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-4-balance-sheet-information-inventories-details Note 4 - Balance Sheet Information - Inventories (Details) Details 35 false false R36.htm 035 - Disclosure - Note 4 - Balance Sheet Information - Other Current Liabilities (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-4-balance-sheet-information-other-current-liabilities-details Note 4 - Balance Sheet Information - Other Current Liabilities (Details) Details 36 false false R37.htm 036 - Disclosure - Note 5 - Leases - Lease Expense (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-5-leases-lease-expense-details Note 5 - Leases - Lease Expense (Details) Details 37 false false R38.htm 037 - Disclosure - Note 5- Leases - Supplemental Cash Flow Information Related to Operating Leases (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-5-leases-supplemental-cash-flow-information-related-to-operating-leases-details Note 5- Leases - Supplemental Cash Flow Information Related to Operating Leases (Details) Details 38 false false R39.htm 038 - Disclosure - Note 5 - Leases - Supplemental Balance Sheet Information Related to Operating Leases (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-5-leases-supplemental-balance-sheet-information-related-to-operating-leases-details Note 5 - Leases - Supplemental Balance Sheet Information Related to Operating Leases (Details) Details 39 false false R40.htm 039 - Disclosure - Note 5 - Leases - Future Minimum Lease Payments (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-5-leases-future-minimum-lease-payments-details Note 5 - Leases - Future Minimum Lease Payments (Details) Details 40 false false R41.htm 040 - Disclosure - Note 6 - Long-term Debt (Details Textual) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-6-longterm-debt-details-textual Note 6 - Long-term Debt (Details Textual) Details http://www.harvardbioscience.com/20230630/role/statement-note-6-longterm-debt-tables 41 false false R42.htm 041 - Disclosure - Note 6 - Long-term Debt - Breakdown of Borrowings (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-6-longterm-debt-breakdown-of-borrowings-details Note 6 - Long-term Debt - Breakdown of Borrowings (Details) Details 42 false false R43.htm 042 - Disclosure - Note 7 - Derivatives (Details Textual) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-7-derivatives-details-textual Note 7 - Derivatives (Details Textual) Details http://www.harvardbioscience.com/20230630/role/statement-note-7-derivatives-tables 43 false false R44.htm 043 - Disclosure - Note 7 - Derivatives - Derivative Instruments (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-7-derivatives-derivative-instruments-details Note 7 - Derivatives - Derivative Instruments (Details) Details 44 false false R45.htm 044 - Disclosure - Note 7 - Derivatives - The Effect of Derivatives Designated as Cash Flow Hedging Instruments (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-7-derivatives-the-effect-of-derivatives-designated-as-cash-flow-hedging-instruments-details Note 7 - Derivatives - The Effect of Derivatives Designated as Cash Flow Hedging Instruments (Details) Details 45 false false R46.htm 045 - Disclosure - Note 8 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-8-fair-value-measurements-assets-and-liabilities-measured-on-a-recurring-basis-details Note 8 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) Details 46 false false R47.htm 046 - Disclosure - Note 9 - Capital Stock and Stock-based Compensation (Details Textual) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-9-capital-stock-and-stockbased-compensation-details-textual Note 9 - Capital Stock and Stock-based Compensation (Details Textual) Details http://www.harvardbioscience.com/20230630/role/statement-note-9-capital-stock-and-stockbased-compensation-tables 47 false false R48.htm 047 - Disclosure - Note 9 - Capital Stock and Stock-based Compensation - Stock Option and Restricted Stock Unit Activity (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-9-capital-stock-and-stockbased-compensation-stock-option-and-restricted-stock-unit-activity-details Note 9 - Capital Stock and Stock-based Compensation - Stock Option and Restricted Stock Unit Activity (Details) Details 48 false false R49.htm 048 - Disclosure - Note 9 - Capital Stock and Stock-based Compensation - Stock-based Compensation Expense (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-9-capital-stock-and-stockbased-compensation-stockbased-compensation-expense-details Note 9 - Capital Stock and Stock-based Compensation - Stock-based Compensation Expense (Details) Details 49 false false R50.htm 049 - Disclosure - Note 9 - Capital Stock and Stock-based Compensation - Black Scholes Assumptions (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-9-capital-stock-and-stockbased-compensation-black-scholes-assumptions-details Note 9 - Capital Stock and Stock-based Compensation - Black Scholes Assumptions (Details) Details 50 false false R51.htm 050 - Disclosure - Note 9 - Capital Stock and Stock-based Compensation - Earnings (Loss) Per Share (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-9-capital-stock-and-stockbased-compensation-earnings-loss-per-share-details Note 9 - Capital Stock and Stock-based Compensation - Earnings (Loss) Per Share (Details) Details http://www.harvardbioscience.com/20230630/role/statement-note-9-capital-stock-and-stockbased-compensation-tables 51 false false R52.htm 051 - Disclosure - Note 10 - Revenues (Details Textual) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-10-revenues-details-textual Note 10 - Revenues (Details Textual) Details http://www.harvardbioscience.com/20230630/role/statement-note-10-revenues-tables 52 false false R53.htm 052 - Disclosure - Note 10 - Revenues - Disaggregation of Revenue (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-10-revenues-disaggregation-of-revenue-details Note 10 - Revenues - Disaggregation of Revenue (Details) Details 53 false false R54.htm 053 - Disclosure - Note 10 - Revenues - Revenue by Geographic Destination (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-10-revenues-revenue-by-geographic-destination-details Note 10 - Revenues - Revenue by Geographic Destination (Details) Details 54 false false R55.htm 054 - Disclosure - Note 10 - Revenues - Deferred Revenue (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-10-revenues-deferred-revenue-details Note 10 - Revenues - Deferred Revenue (Details) Details 55 false false R56.htm 055 - Disclosure - Note 10 - Revenues - Warranties (Details) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-10-revenues-warranties-details Note 10 - Revenues - Warranties (Details) Details 56 false false R57.htm 056 - Disclosure - Note 11 - Income Tax (Details Textual) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-11-income-tax-details-textual Note 11 - Income Tax (Details Textual) Details http://www.harvardbioscience.com/20230630/role/statement-note-11-income-tax- 57 false false R58.htm 057 - Disclosure - Note 12 - Commitments and Contingent Liabilities (Details Textual) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-12-commitments-and-contingent-liabilities-details-textual Note 12 - Commitments and Contingent Liabilities (Details Textual) Details http://www.harvardbioscience.com/20230630/role/statement-note-12-commitments-and-contingent-liabilities 58 false false R59.htm 058 - Disclosure - Note 13 - Litigation Settlement (Details Textual) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-13-litigation-settlement-details-textual Note 13 - Litigation Settlement (Details Textual) Details http://www.harvardbioscience.com/20230630/role/statement-note-13-litigation-settlement 59 false false R60.htm 059 - Disclosure - Note 14 - Product Line Disposition (Details Textual) Sheet http://www.harvardbioscience.com/20230630/role/statement-note-14-product-line-disposition-details-textual Note 14 - Product Line Disposition (Details Textual) Details http://www.harvardbioscience.com/20230630/role/statement-note-14-product-line-disposition 60 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 15 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, hbio:LiabilityForContingentIndemnificationObligations, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:ContractWithCustomerLiabilityRevenueRecognized, us-gaap:PreferredStockNoParValue, us-gaap:PreferredStockSharesAuthorized - hboi20230630_10q.htm 8, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 hboi20230630_10q.htm ex_552683.htm ex_552684.htm ex_552685.htm ex_552686.htm hbio-20230630.xsd hbio-20230630_cal.xml hbio-20230630_def.xml hbio-20230630_lab.xml hbio-20230630_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true